Tag Archives: VTVT

Top 10 Value Stocks To Own For 2019

California State Teachers Retirement System trimmed its stake in shares of Kohl’s Co. (NYSE:KSS) by 3.4% in the first quarter, HoldingsChannel.com reports. The fund owned 325,416 shares of the company’s stock after selling 11,625 shares during the quarter. California State Teachers Retirement System’s holdings in Kohl’s were worth $21,318,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in KSS. NuWave Investment Management LLC lifted its position in shares of Kohl’s by 6,537.0% during the 1st quarter. NuWave Investment Management LLC now owns 1,792 shares of the company’s stock valued at $117,000 after acquiring an additional 1,765 shares during the period. Avestar Capital LLC raised its holdings in shares of Kohl’s by 987.3% during the 1st quarter. Avestar Capital LLC now owns 2,218 shares of the company’s stock worth $129,000 after buying an additional 2,014 shares in the last quarter. Loomis Sayles & Co. L P acquired a new position in shares of Kohl’s during the 1st quarter worth $182,000. Focused Wealth Management Inc acquired a new position in shares of Kohl’s during the 4th quarter worth $201,000. Finally, Parametrica Management Ltd acquired a new position in shares of Kohl’s during the 1st quarter worth $203,000.

Top 10 Value Stocks To Own For 2019: Ryder System Inc.(R)

Advisors’ Opinion:

  • [By Shane Hupp]

    Mackay Shields LLC bought a new stake in shares of Ryder (NYSE:R) in the 1st quarter, according to its most recent filing with the SEC. The institutional investor bought 97,749 shares of the transportation company’s stock, valued at approximately $7,115,000. Mackay Shields LLC owned about 0.18% of Ryder at the end of the most recent reporting period.

  • [By Joseph Griffin]

    Media stories about Ryder (NYSE:R) have trended somewhat positive this week, Accern reports. Accern identifies positive and negative news coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Ryder earned a media sentiment score of 0.09 on Accern’s scale. Accern also gave news coverage about the transportation company an impact score of 44.4340282605262 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

  • [By Max Byerly]

    Earnest Partners LLC increased its position in shares of Ryder System, Inc. (NYSE:R) by 3.0% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 265,257 shares of the transportation company’s stock after purchasing an additional 7,653 shares during the period. Earnest Partners LLC’s holdings in Ryder System were worth $19,308,000 at the end of the most recent quarter.

Top 10 Value Stocks To Own For 2019: ENGlobal Corporation(ENG)

Advisors’ Opinion:

  • [By Max Byerly]

    ENGlobal (NASDAQ:ENG) will be announcing its earnings results before the market opens on Wednesday, May 9th.

    ENGlobal (NASDAQ:ENG) last released its quarterly earnings data on Thursday, March 15th. The construction company reported ($0.08) earnings per share for the quarter. ENGlobal had a negative net margin of 29.16% and a negative return on equity of 17.18%. The firm had revenue of $14.43 million during the quarter.

  • [By Stephan Byrd]

    Enigma (CURRENCY:ENG) traded 0.7% higher against the US dollar during the 24 hour period ending at 10:00 AM ET on June 17th. During the last seven days, Enigma has traded down 12% against the US dollar. Enigma has a market capitalization of $104.94 million and $2.86 million worth of Enigma was traded on exchanges in the last 24 hours. One Enigma token can now be bought for about $1.40 or 0.00021533 BTC on popular cryptocurrency exchanges including HitBTC, Vebitcoin, OKEx and GOPAX.

Top 10 Value Stocks To Own For 2019: Addus HomeCare Corporation(ADUS)

Advisors’ Opinion:

  • [By Ethan Ryder]

    BidaskClub upgraded shares of Addus Homecare (NASDAQ:ADUS) from a buy rating to a strong-buy rating in a report published on Saturday.

    Several other equities analysts have also recently weighed in on the stock. Stephens set a $56.00 price target on shares of Addus Homecare and gave the company a buy rating in a research report on Monday, April 2nd. Robert W. Baird set a $43.00 price target on shares of Addus Homecare and gave the company a hold rating in a research report on Wednesday, March 14th. ValuEngine raised shares of Addus Homecare from a hold rating to a buy rating in a research report on Wednesday, May 2nd. Finally, Zacks Investment Research cut shares of Addus Homecare from a buy rating to a strong sell rating in a research report on Monday, June 11th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company’s stock. The stock currently has a consensus rating of Buy and an average target price of $51.00.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Addus Homecare (ADUS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Addus HomeCare (NASDAQ:ADUS) was downgraded by BidaskClub from a “strong-buy” rating to a “buy” rating in a report issued on Saturday.

Top 10 Value Stocks To Own For 2019: Territorial Bancorp Inc.(TBNK)

Advisors’ Opinion:

  • [By Max Byerly]

    Shares of Territorial Bancorp Inc (NASDAQ:TBNK) have earned a consensus recommendation of “Hold” from the seven analysts that are presently covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is $33.50.

  • [By Stephan Byrd]

    Territorial Bancorp Inc (NASDAQ:TBNK) Director David S. Murakami sold 4,394 shares of Territorial Bancorp stock in a transaction dated Monday, June 11th. The shares were sold at an average price of $30.67, for a total value of $134,763.98. Following the completion of the transaction, the director now owns 27,494 shares of the company’s stock, valued at approximately $843,240.98. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.

  • [By Stephan Byrd]

    Shares of Territorial Bancorp (NASDAQ:TBNK) have been given an average rating of “Hold” by the seven ratings firms that are presently covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating on the company. The average 1-year price objective among brokerages that have issued ratings on the stock in the last year is $33.50.

Top 10 Value Stocks To Own For 2019: Amarin Corporation PLC(AMRN)

Advisors’ Opinion:

  • [By Shane Hupp]

    BidaskClub upgraded shares of Amarin (NASDAQ:AMRN) from a strong sell rating to a sell rating in a report released on Friday morning.

    A number of other equities research analysts have also weighed in on AMRN. ValuEngine upgraded shares of Amarin from a sell rating to a hold rating in a report on Wednesday. Cantor Fitzgerald set a $10.00 price objective on shares of Amarin and gave the stock a buy rating in a report on Wednesday. HC Wainwright reiterated a buy rating on shares of Amarin in a report on Thursday, March 1st. Finally, Zacks Investment Research lowered shares of Amarin from a hold rating to a sell rating in a report on Friday, March 2nd. Two investment analysts have rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the company. Amarin currently has a consensus rating of Hold and a consensus target price of $7.75.

  • [By Shane Hupp]

    Amarin (NASDAQ: AMRN) and Aptevo Therapeutics (NASDAQ:APVO) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, earnings, risk, dividends, institutional ownership, analyst recommendations and profitability.

  • [By Todd Campbell]

    After management reported that the last patient visit has occurred in its long-term cardiovascular outcomes study of Vascepa, shares in Amarin Corporation Plc (NASDAQ:AMRN) jumped by 10.2% on Thursday.

Top 10 Value Stocks To Own For 2019: Magellan Midstream Partners L.P.(MMP)

Advisors’ Opinion:

  • [By ]

    Cramer and the AAP team are looking for opportunities to trim stocks into strength based out of discipline. That means trimming Magellan Midstream Partners (MMP) . Find out what they’re telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.

  • [By Matthew DiLallo]

    Meanwhile, the return multiples for many of the projects under development by Magellan Midstream Partners (NYSE:MMP) are in the six- to eight-times EBITDA range. Because of that, the $1.7 billion of expansion projects Magellan currently has underway only will generate about $250 million in incidental EBITDA. That’s partially why Magellan Midstream expects to grow its payout at a slower pace of 8% this year and a 5% to 8% annual rate in 2019 and 2020, even though it plans on paying out the same percentage of its cash flow as ONEOK.

  • [By ]

    That means pipelines are equally busy carrying all that raw crude into these refineries and then carrying out gasoline, diesel and other finished products. So you’d think these would be boon times for Magellan Midstream Partners (NYSE: MMP), which owns 10,000 miles of pipeline that connect with 50% of the nation’s refinery capacity.

Top 10 Value Stocks To Own For 2019: Texas Instruments Incorporated(TXN)

Advisors’ Opinion:

  • [By Chris Lange]

    Texas Instruments Inc. (NASDAQ: TXN) is set to report its fourth-quarter results on Tuesday. The analysts consensus estimates are EPS of $1.09 and $3.74 billion in revenue. Shares were changing hands at $116.83 as last week came to a close. The consensus price target is $105.41, and the stock has a 52-week range of $74.16 to $119.98.

  • [By Lisa Levin] Gainers
    Vicor Corporation (NASDAQ: VICR) rose 19.7 percent to $35 in pre-market trading. Vicor posted Q1 earnings of $0.10 per share on sales of $65.2 million.
    Check-Cap Ltd. (NASDAQ: CHEK) shares rose 13.5 percent to $16.88 in pre-market trading after climbing 104.82 percent on Tuesday.
    Cree, Inc. (NASDAQ: CREE) shares rose 11.3 percent to $43.81 in pre-market trading as the company reported upbeat results for its third quarter on Tuesday.
    The Clorox Company (NYSE: CLX) rose 9.6 percent to $125.98 in pre-market trading.
    Aduro BioTech, Inc. (NASDAQ: ADRO) rose 5.8 percent to $7.25 in pre-market trading after falling 1.44 percent on Tuesday.
    STMicroelectronics N.V. (NYSE: STM) rose 5.2 percent to $22.42 in pre-market trading after reporting Q1 results.
    Twitter, Inc. (NYSE: TWTR) rose 5.2 percent to $32.05 in pre-market trading as the company reported stronger-than-expected results for its first quarter on Wednesday.
    Credit Suisse Group AG (NYSE: CS) rose 5 percent to $17.11 in pre-market trading following strong Q1 results.
    Harmony Gold Mining Company Limited (NYSE: HMY) shares rose 4.4 percent to $2.02 in pre-market trading.
    22nd Century Group, Inc. (NYSE: XXII) rose 4.9 percent to $2.15 in pre-market trading after dropping 8.07 percent on Tuesday.
    Texas Instruments Incorporated (NASDAQ: TXN) rose 4.1 percent to $102.40 in pre-market trading after the company reported stronger-than-expected earnings for its first quarter on Tuesday.
    iRobot Corporation (NASDAQ: IRBT) rose 3.3 percent to $61 in pre-market trading following upbeat quarterly earnings.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Lee Jackson]

    This old-school tech company offers solid value.Texas Instruments Inc. (NASDAQ: TXN) is a broad-based supplier of semiconductor components, ranging from digital signal processors to high-performance analog components to digital light-processing technology and calculators.Some 65% of Texas Instruments sales are exposed to the well-diversified, business-to-business industrial, automotive, communications infrastructure and enterprise markets.

  • [By Keith Speights]

    The way to determine where a puck is going to be requires evaluating its direction and speed. I used a similar approach to identify five stocks with fast-growing dividends: Boeing (NYSE:BA), Amgen (NASDAQ:AMGN), CVS Health (NYSE:CVS), Texas Instruments (NASDAQ:TXN), and AbbVie (NYSE:ABBV). Here’s why these stocks could be great picks for dividend-seeking investors.

Top 10 Value Stocks To Own For 2019: vTv Therapeutics Inc.(VTVT)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    ARMO BioSciences, Inc. (NASDAQ: ARMO) shares rose 67.5 percent to $49.96 in pre-market trading after Eli Lilly and Company (NYSE: LLY) announced plans to acquire ARMO BioSciences for $50 per share.
    Turtle Beach Corporation (NASDAQ: HEAR) rose 62.8 percent to $11.30 in pre-market trading after the company reported Q1 results and raised its FY18 outlook.
    vTv Therapeutics Inc. (NASDAQ: VTVT) rose 23.4 percent to $2.11 in pre-market trading following announcement that the company will pre-specify new subgroup with the FDA and report Phase 3 Part B results in June.
    Resonant Inc. (NASDAQ: RESN) rose 19.1 percent to $5.00 in pre-market trading after reporting Q1 results.
    RXi Pharmaceuticals Corporation (NASDAQ: RXII) rose 17.7 percent to $2.39 in pre-market trading following Q1 results.
    Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 15.2 percent to $2.20 in pre-market trading after French company Total announced plans to acquire 25 percent stake in Clean Energy Fuels for $83.4 million.
    Everspin Technologies, Inc. (NASDAQ: MRAM) rose 14.6 percent to $8.50 in pre-market trading after the company reported strong results for its first quarter.
    Carvana Co. (NYSE: CVNA) shares rose 11 percent to $27.50 in pre-market trading after reporting upbeat Q1 sales.
    Sunrun Inc. (NASDAQ: RUN) rose 8.9 percent to $10.70 in pre-market trading following upbeat quarterly earnings.
    MediciNova, Inc. (NASDAQ: MNOV) rose 8.1 percent to $11.35 in pre-market trading after the company announced opening of Investigational New Drug Application for MN-166 (ibudilast) in glioblastoma.
    New Gold Inc. (NYSE: NGD) shares rose 7.7 percent to $2.65 in pre-market trading after the company reported that its President and CEO Hannes Portmann left the company. The company named Raymond Threlkeld as successor.
    Otter Tail Corporation (NASDAQ: OTTR) shares rose 7.4 percent to $46.60 in the pre-market trading session.
    Himax Technologies, Inc. (NASDAQ: HIMX) shares rose
  • [By Lisa Levin] Gainers
    Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) rose 65.5 percent to $179.50 in pre-market trading. Madrigal Pharma disclosed that MGL-3196 achieved liver biopsy endpoints in patients with NASH at 36 weeks in Phase 2 trial.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) rose 34.8 percent to $6.70 in pre-market trading after falling 4.42 percent on Wednesday.
    vTv Therapeutics Inc. (NASDAQ: VTVT) shares rose 31.5 percent to $2.19 in pre-market trading after the company reported a licensing deal with Newsoara Biopharma to rights for vTv's PDE4 Inhibitor in China and other Pacific Rim territories.
    Curis, Inc. (NASDAQ: CRIS) shares rose 27.2 percent to $2.90 in pre-market trading after the company reported FDA Fast Track designation for CUDC-907 development in patients with relapse, refractory diffuse large B-cell lymphoma.
    Kitov Pharma Ltd (NASDAQ: KTOV) rose 16.7 percent to $2.51 in pre-market trading.
    Tilly's, Inc. (NYSE: TLYS) rose 14.7 percent to $14.00 in pre-market trading as the company reported better-than-expected earnings for its first quarter and issued a strong Q2 outlook.
    Express, Inc. (NYSE: EXPR) rose 14.3 percent to $10.49 in pre-market trading after the company reported better-than-expected results for its first quarter.
    NGL Energy Partners LP (NYSE: NGL) rose 12.8 percent to $12.10 in pre-market trading after reporting Q4 earnings beat.
    J.Jill, Inc. (NYSE: JILL) rose 11.3 percent to $6.90 in pre-market trading after the company posted upbeat quarterly earnings.
    TapImmune, Inc. (NASDAQ: TPIV) shares rose 10 percent to $5.60 in pre-market trading after climbing 24.15 percent on Wednesday.
    Frontline Ltd. (NYSE: FRO) rose 9.8 percent to $5.74 in pre-market trading after Q1 results beat estimates.
    Tech Data Corporation (NASDAQ: TECD) rose 8.8 percent to $89.65 in pre-market trading following better-than-expected Q1 earnings.
    TransEnterix, Inc. (NYSE: TRXC) shares rose 7.1 percent to $3.65 in pre-market tra
  • [By Chris Lange]

    vTv Therapeutics Inc. (NASDAQ: VTVT) shares saw a massive gain early on Thursday after the firm announced an exclusive licensing agreement with Newsoara Biopharma. This deal is for the rights to develop and commercialize vTv Therapeutics PDE4 Inhibitor program in mainland China, Hong Kong, Macau, Taiwan and other Pacific Rim countries.

  • [By Lisa Levin] Gainers
    Turtle Beach Corporation (NASDAQ: HEAR) surged 87.1 percent to $12.98 after the company reported Q1 results and raised its FY18 outlook.
    ARMO BioSciences, Inc. (NASDAQ: ARMO) shares jumped 66.8 percent to $49.735 after Eli Lilly and Company (NYSE: LLY) announced plans to acquire ARMO BioSciences for $50 per share.
    vTv Therapeutics Inc. (NASDAQ: VTVT) gained 34 percent to $2.2920 following announcement that the company will pre-specify new subgroup with the FDA and report Phase 3 Part B results in June.
    Prestige Brands Holdings, Inc. (NYSE: PBH) climbed 22.3 percent to $34.84 after the company posted upbeat Q4 earnings.
    Depomed, Inc. (NASDAQ: DEPO) shares jumped 22.2 percent to $7.28 following better-than-expected Q1 earnings.
    Everspin Technologies, Inc. (NASDAQ: MRAM) gained 19.8 percent to $8.89 after the company reported strong results for its first quarter.
    Luxfer Holdings PLC (NYSE: LXFR) surged 19.8 percent to $17.10 following Q1 results.
    Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 18.3 percent to $2.26 after French company Total announced plans to acquire 25 percent stake in Clean Energy Fuels for $83.4 million.
    Intelligent Systems Corporation (NYSE: INS) gained 17 percent to $7.116.
    Green Dot Corporation (NYSE: GDOT) surged 15.3 percent to $73.00 after reporting upbeat Q1 earnings.
    The Chefs' Warehouse, Inc. (NASDAQ: CHEF) climbed 15 percent to $28.85. Chefs' Warehouse posted Q1 earnings of $0.03 per share on sales of $318.6 million.
    Westport Fuel Systems Inc. (NASDAQ: WPRT) rose 14.2 percent to $2.9701.
    Wright Medical Group N.V. (NASDAQ: WMGI) jumped 13.8 percent to $23.87 after reporting upbeat quarterly earnings.
    Diplomat Pharmacy, Inc. (NYSE: DPLO) gained 13.4 percent to $22.70. Diplomat named Brian Griffin as Chairman and CEO.
    Carvana Co. (NYSE: CVNA) shares rose 13 percent to $27.97 after reporting upbeat Q1 sales.
    Prothena Corporation plc (NASDAQ: PRTA) gained 12 percent to $15.19
  • [By Money Morning News Team]

    vTv Therapeutics Inc. (Nasdaq: VTVT) is a North Carolina-based biopharmaceutical company.

    vTv concentrates on developing orally administered, small-molecule drugs to treat a variety of issues such as diabetes and Alzheimer’s disease.

Top 10 Value Stocks To Own For 2019: Prudential Financial Inc.(PRU)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Prudential Financial (PRU)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    These are some of the headlines that may have effected Accern Sentiment Analysis’s analysis:

    Get Prudential Financial alerts:

    Prudential (PUK) Presents At 2018 Deutsche Bank Annual Global Financial Services Conference – Slideshow (seekingalpha.com) Leston Welsh joins Prudential Group Insurance as head of Disability and Absence Management (finance.yahoo.com) Contrasting Prudential Financial (PRU) & Old Mutual (ODMTY) (americanbankingnews.com) Prudential again accused with unauthorised money deduction (vir.com.vn) An Application for the Trademark MULLINTBG Has Been Filed by Prudential Insurance Company (insurancenewsnet.com)

    Prudential Financial traded down $5.05, hitting $94.97, during midday trading on Tuesday, MarketBeat Ratings reports. 2,919,216 shares of the company’s stock were exchanged, compared to its average volume of 2,144,103. The company has a current ratio of 0.12, a quick ratio of 0.12 and a debt-to-equity ratio of 0.35. The firm has a market cap of $42.01 billion, a PE ratio of 8.98, a P/E/G ratio of 0.97 and a beta of 1.52. Prudential Financial has a one year low of $94.51 and a one year high of $127.14.

  • [By Shane Hupp]

    NN Investment Partners Holdings N.V. increased its holdings in Prudential Financial Inc (NYSE:PRU) by 0.1% during the 2nd quarter, Holdings Channel reports. The firm owned 2,197,076 shares of the financial services provider’s stock after buying an additional 2,780 shares during the period. Prudential Financial accounts for approximately 1.5% of NN Investment Partners Holdings N.V.’s portfolio, making the stock its 10th largest position. NN Investment Partners Holdings N.V.’s holdings in Prudential Financial were worth $205,450,000 at the end of the most recent reporting period.

  • [By Ethan Ryder]

    State of Tennessee Treasury Department lessened its position in Prudential Financial Inc (NYSE:PRU) by 29.7% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 312,450 shares of the financial services provider’s stock after selling 132,238 shares during the period. State of Tennessee Treasury Department owned approximately 0.07% of Prudential Financial worth $32,354,000 at the end of the most recent reporting period.

  • [By Ethan Ryder]

    American Equity Investment Life (NYSE: AEL) and Prudential Financial (NYSE:PRU) are both finance companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, earnings, risk, analyst recommendations, profitability, dividends and valuation.

Top 10 Value Stocks To Own For 2019: Guess?, Inc.(GES)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Guess (GES)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Garrett Baldwin]

    On Tuesday, the Trump administration said it would press ahead with 25% tariffs on roughly $50 billion in Chinese goods. As U.S. Trade Secretary Wilbur Ross prepares to head to Beijing to discuss trade this week, the Trump administration is demanding that China address ongoing theft of U.S. intellectual property.
    Ahead of Friday’s jobs report, Automatic Data Processing (NYSE: ADP) reported that private jobs increased by 178,000 during May. That figure was actually 12,000 behind what the markets were anticipating. Job growth appears to be slowing down as the firm also revised its jobs figure for April downward, from 204,000 new positions to 163,000.
    Three Stocks to Watch Today: KORS, HP, KMI
    Michael Kors Holdings Ltd.(NYSE: KORS) stock was off 3.2% in pre-market hours after the company reported earnings before the bell. The luxury retailer reported earnings per share (EPS) of $0.63, a figure that topped Wall Street expectations of $0.60. The firm also beat revenue expectations and reported an increase in same-store sales. However, the firm’s earnings forecast for the year ahead came in lower than expectations, a factor that pushed its stock lower on Wednesday morning.
    Shares of HP Inc. (NYSE: HP) were up slightly after the company raised its full-year outlook and topped Wall Street earnings expectations on Tuesday. The company cited stronger demand in desktops and notebooks for its financial performance. The firm matched EPS expectations of $0.48. However, revenue came in at $14.0 billion, a figure that easily beat forecasts of $13.59.
    The Canadian government announced plans to purchase the Trans Mountain pipeline from Kinder Morgan Canada Ltd. (NYSE: KML) for $3.5 billion. The Canadian government said that the deal was the only way to ensure that the long-awaited project could proceed. The pipeline runs from the Alberta oil sands to a port all the way in British Columbia along the Pacific Ocean. The pipeline is designed to give Canadian crude grea

  • [By Dan Caplinger]

    Turnarounds are always difficult, because no investor wants to wait forever for a recovery. Guess? (NYSE:GES) has dealt with the normal ups and downs of its market as well as some unusual situations affecting its reputation, and that’s made some people think twice about counting on the jeans maker’s attempts to mount a full turnaround.

  • [By Steve Symington]

    Shares of Guess? Inc. (NYSE:GES) fell 19.4% on Thursday after the clothing retailer announced solid fiscal first-quarter 2019 results but followed with underwhelming forward earnings guidance.

  • [By Shane Hupp]

    Guess (NYSE:GES) issued an update on its second quarter earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $0.27-0.30 for the period, compared to the Thomson Reuters consensus estimate of $0.30. The company issued revenue guidance of $654-663 million, compared to the consensus revenue estimate of $621.68 million.Guess also updated its FY19 guidance to $0.88-0.99 EPS.

Hot Small Cap Stocks For 2019

Dollar stores, selling a variety of inexpensive household goods, have been solid growth stories over the past decade, observes Doug Gerlach, editor of Small Cap Informer.

Recently these companies have come under pressure, in part due to rising costs for healthcare and rent. But for the long-term, these stores appeal to millennials, who want to spend less on essentials from soap to paper plates.

Five Below (FIVE), based in Philadelphia, occupies a fast-growing niche in this space. It is our Top Pick for small-cap growth stock investors.

Its sells a dizzy array of merchandise targeted at youngsters costing, as the name suggests, less than $5. About half of sales fall into the leisure category, 30% is fashion and home merchandise and 20% is party and snack goods.

Five Below has plenty of room for growth. From the current base of 500 stores in 31 states, management believes there’s room for 2,000 or more stores in the U.S.

Hot Small Cap Stocks For 2019: vTv Therapeutics Inc.(VTVT)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) jumped 124.8 percent to $243.725 in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed a statistical significance in the primary endpoint of lowering liver fat at 12 weeks and also 36 weeks.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) gained 63.4 percent to $8.12 after falling 4.42 percent on Wednesday.
    Takung Art Co., Ltd. (NYSE: TKAT) rose 43.3 percent to $2.9094
    vTv Therapeutics Inc. (NASDAQ: VTVT) shares climbed 29.7 percent to $2.16 after the company reported a licensing deal with Newsoara Biopharma to rights for vTv's PDE4 Inhibitor in China and other Pacific Rim territories.
    Akers Biosciences, Inc. (NASDAQ: AKER) gained 26.2 percent to $0.4109. The developer of rapid health information technologies said Wednesday afternoon it was granted a 180-day extension from the Nasdaq Stock Market to meet the requirement of a minimum $1.00 per share closing bid price for 10 straight days.
    Genprex, Inc. (NASDAQ: GNPX) rose 22.2 percent to $11.6254. Genprex reported engagement of WIRB-Copernicus Group to provide clinical trial services to support Oncoprex clinical trial program.
    J.Jill, Inc. (NYSE: JILL) gained 21 percent to $7.506 after the company posted upbeat quarterly earnings.
    Urban One, Inc. (NASDAQ: UONE) gained 19.7 percent to $3.95 after rising 78.38 percent on Wednesday.
    TapImmune, Inc. (NASDAQ: TPIV) shares gained 18.5 percent to $6.03 after climbing 24.15 percent on Wednesday.
    Kirkland's, Inc. (NASDAQ: KIRK) rose 17.3 percent to $12.95 after reporting upbeat Q1 results.
    CymaBay Therapeutics, Inc. (NASDAQ: CBAY) shares gained 15.1 percent to $13.210.
    The Brink's Company (NYSE: BCO) climbed 14.2 percent to $77.875 as the company announced plans to acquire Dunbar Armored for $520 million in cash.
    Keysight Technologies, Inc. (NYSE: KEY
  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Aceto Corporation (NASDAQ: ACET) fell 41.9 percent to $4.30 in pre-market trading. ACETO board disclosed that it is taking proactive steps to address business and financial challenges. Canaccord Genuity downgraded Aceto from Buy to Sell.
    Helios and Matheson Analytics Inc. (NASDAQ: HMNY) fell 25.3 percent to $2.86 in pre-market trading after reporting an ATM offering of $150 million.
    Pier 1 Imports, Inc. (NYSE: PIR) fell 17.4 percent to $2.86 in pre-market trading after reporting a fourth quarter sales miss. Comps were down 7.5 percent in the quarter.
    Sleep Number Corporation (NASDAQ: SNBR) fell 12.4 percent to $32.00 in pre-market trading following a first quarter earnings miss.
    Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) fell 10.2 percent to $11.90 in pre-market trading on news of $125 million convertible debt offering.
    Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) shares fell 8 percent to $8.02 in pre-market trading after dropping 2.02 percent on Wednesday.
    Exponent, Inc. (NASDAQ: EXPO) shares fell 5.6 percent to $80 in pre-market trading.
    Lumentum Holdings Inc. (NASDAQ: LITE) shares fell 4.8 percent to $60.00 in pre-market trading after rising 1.78 percent on Wednesday.
    vTv Therapeutics Inc. (NASDAQ: VTVT) fell 4.6 percent to $2.10 in pre-market trading after surging 84.87 percent on Wednesday.
    Taiwan Semiconductor Manufacturing Company Limited (NYSE: TSM) shares fell 4.5 percent to $40.07 in pre-market trading after the company reported Q1 results.
    Align Technology, Inc.. (NASDAQ: ALGN) fell 3.5 percent to $267.40 in pre-market trading after rising 1.61 percent on Wednesday.
    Transocean Ltd. (NYSE: RIG) shares fell 3.5 percent to $12 in pre-market trading after the company issued quarterly fleet status report.
    GoPro, Inc. (NASDAQ: GPRO) fell 3.2 percent to $4.90 in pre-market trading.
    Unilever PLC (NYSE: UL) fell 2.6 percent to $54.73 in pre-market

  • [By Lisa Levin] Gainers
    Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares surged 144.96 percent to close at $265.61 on Thursday in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed a statistical significance in the primary endpoint of lowering liver fat at 12 weeks and also 36 weeks.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) shares rose 101.01 percent to close at $9.99 on Thursday after falling 4.42 percent on Wednesday.
    Akers Biosciences, Inc. (NASDAQ: AKER) jumped 45.58 percent to close at $0.474. The developer of rapid health information technologies said Wednesday afternoon it was granted a 180-day extension from the Nasdaq Stock Market to meet the requirement of a minimum $1.00 per share closing bid price for 10 straight days.
    Kitov Pharma Ltd (NASDAQ: KTOV) gained 40.93 percent to close at $3.03 after the FDA approved Kitov's Consensi for the treatment of osteoarthritis pain and hypertension.
    China Customer Relations Centers, Inc. (NASDAQ: CCRC) rose 28.21 percent to close at $19.86.
    J.Jill, Inc. (NYSE: JILL) climbed 26.45 percent to close at $7.84 after the company posted upbeat quarterly earnings.
    Curis, Inc. (NASDAQ: CRIS) shares climbed 21.93 percent to close at $2.78 in reaction to an encouraging FDA update. The biotechnology company that focuses on therapies for the treatment of cancer said the FDA granted a Fast Track designation for fimepinostat (CUDC-907) in patients with relapsed or refractory.
    Boxlight Corporation (NASDAQ: BOXL) gained 21.23 percent to close at $7.48.
    Kirkland's, Inc. (NASDAQ: KIRK) rose 16.21 percent to close at $12.83 after reporting upbeat Q1 results.
    The Brink's Company (NYSE: BCO) jumped 16.2 percent to close at $79.25 as the company announced plans to acquire Dunbar Armored for $520 million in cash.
    Applied Optoelectronics, Inc. (NASDAQ: AAOI) rose 15.14 percent to c
  • [By Lisa Levin] Gainers
    ARMO BioSciences, Inc. (NASDAQ: ARMO) shares rose 67.5 percent to $49.96 in pre-market trading after Eli Lilly and Company (NYSE: LLY) announced plans to acquire ARMO BioSciences for $50 per share.
    Turtle Beach Corporation (NASDAQ: HEAR) rose 62.8 percent to $11.30 in pre-market trading after the company reported Q1 results and raised its FY18 outlook.
    vTv Therapeutics Inc. (NASDAQ: VTVT) rose 23.4 percent to $2.11 in pre-market trading following announcement that the company will pre-specify new subgroup with the FDA and report Phase 3 Part B results in June.
    Resonant Inc. (NASDAQ: RESN) rose 19.1 percent to $5.00 in pre-market trading after reporting Q1 results.
    RXi Pharmaceuticals Corporation (NASDAQ: RXII) rose 17.7 percent to $2.39 in pre-market trading following Q1 results.
    Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 15.2 percent to $2.20 in pre-market trading after French company Total announced plans to acquire 25 percent stake in Clean Energy Fuels for $83.4 million.
    Everspin Technologies, Inc. (NASDAQ: MRAM) rose 14.6 percent to $8.50 in pre-market trading after the company reported strong results for its first quarter.
    Carvana Co. (NYSE: CVNA) shares rose 11 percent to $27.50 in pre-market trading after reporting upbeat Q1 sales.
    Sunrun Inc. (NASDAQ: RUN) rose 8.9 percent to $10.70 in pre-market trading following upbeat quarterly earnings.
    MediciNova, Inc. (NASDAQ: MNOV) rose 8.1 percent to $11.35 in pre-market trading after the company announced opening of Investigational New Drug Application for MN-166 (ibudilast) in glioblastoma.
    New Gold Inc. (NYSE: NGD) shares rose 7.7 percent to $2.65 in pre-market trading after the company reported that its President and CEO Hannes Portmann left the company. The company named Raymond Threlkeld as successor.
    Otter Tail Corporation (NASDAQ: OTTR) shares rose 7.4 percent to $46.60 in the pre-market trading session.
    Himax Technologies, Inc. (NASDAQ: HIMX) shares rose

Hot Small Cap Stocks For 2019: Owens-Illinois Inc.(OI)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Owens-Illinois (OI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Todd Campbell, Rich Smith, and Neha Chamaria]

    There isn’t much love forOwens Corning (NYSE:OI),Camping World Holdings(NYSE:CWH), and Oceaneering International (NYSE:OII)on Wall Street right now, but that could be about to change. Some of our top Motley Fool investors think the tough timesthat have soured the mood of institutional investors on these stocks could be ending and that could make these stocks bargains worth buying.

  • [By Ethan Ryder]

    An issue of Owens-Illinois Inc (NYSE:OI) bonds rose 1.1% against their face value during trading on Thursday. The debt issue has a 5% coupon and is set to mature on January 15, 2022. The debt is now trading at $99.50 and was trading at $99.88 one week ago. Price moves in a company’s bonds in credit markets sometimes predict parallel moves in its share price.

Hot Small Cap Stocks For 2019: Virtu Financial, Inc.(VIRT)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    Celgene Corporation (NASDAQ: CELG) is projected to report quarterly earnings at $1.96 per share on revenue of $3.46 billion.
    Aon plc (NYSE: AON) is expected to report quarterly earnings at $2.8 per share on revenue of $2.93 billion.
    American Axle & Manufacturing Holdings, Inc. (NYSE: AXL) is estimated to report quarterly earnings at $0.81 per share on revenue of $1.75 billion.
    Alibaba Group Holding Limited (NYSE: BABA) is expected to report quarterly earnings at $0.88 per share on revenue of $9.27 billion.
    LifePoint Health, Inc. (NASDAQ: LPNT) is projected to report quarterly earnings at $1.13 per share on revenue of $1.62 billion.
    V.F. Corporation (NYSE: VFC) is estimated to report quarterly earnings at $0.65 per share on revenue of $2.90 billion.
    Newell Brands Inc. (NYSE: NWL) is expected to report quarterly earnings at $0.26 per share on revenue of $3.05 billion.
    Titan International, Inc. (NYSE: TWI) is projected to report quarterly earnings at $0.04 per share on revenue of $407.27 million.
    Boise Cascade Company (NYSE: BCC) is expected to report quarterly earnings at $0.45 per share on revenue of $1.09 billion.
    Cheniere Energy, Inc. (NYSE: LNG) is estimated to report quarterly earnings at $0.39 per share on revenue of $1.59 billion.
    Cboe Global Markets, Inc. (NASDAQ: CBOE) is projected to report quarterly earnings at $1.24 per share on revenue of $308.05 million.
    ITT Inc. (NYSE: ITT) is estimated to report quarterly earnings at $0.73 per share on revenue of $683.96 million.
    Fred's, Inc. (NASDAQ: FRED) is expected to report quarterly loss at $0.19 per share on revenue of $551.00 million.
    Virtu Financial, Inc. (NASDAQ: VIRT) is projected to report quarterly earnings at $0.52 per share on revenue of $288.31 million.
    Cheniere Energy Partners, L.P. (NYSE: CQP) is expected to report quarterly earnings at $0.57 per share on revenue of $1.38 billion.
    Genesis Energy, L.P
  • [By Joseph Griffin]

    Virtu Financial (NASDAQ: VIRT) is one of 31 publicly-traded companies in the “Security brokers & dealers” industry, but how does it weigh in compared to its competitors? We will compare Virtu Financial to similar companies based on the strength of its earnings, risk, valuation, dividends, profitability, institutional ownership and analyst recommendations.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Extreme Networks, Inc. (NASDAQ: EXTR) fell 26 percent to $8.70 in pre-market trading after the company reported downbeat earnings for its third quarter and issued weak Q4 guidance.
    Caesarstone Ltd. (NASDAQ: CSTE) shares fell 12.5 percent to $16.15 in pre-market trading after the company reported downbeat Q1 results and lowered its FY18 sales forecast.
    MINDBODY, Inc. (NASDAQ: MB) fell 11.7 percent to $38.65 in pre-market trading following mixed Q1 results.
    Vivint Solar, Inc. (NYSE: VSLR) fell 10 percent to $3.60 in pre-market trading after reporting Q1 miss.
    Applied Optoelectronics, Inc. (NASDAQ: AAOI) shares fell 10 percent to $31.63 in pre-market trading after reporting a Q1 earnings miss at 28 cents per share, 5 cents below estimates.
    Monster Beverage Corporation (NASDAQ: MNST) fell 7.7 percent to $49.00 in pre-market trading after reporting downbeat quarterly earnings.
    MaxLinear, Inc. (NYSE: MXL) fell 6.1 percent to $22.39 in pre-market trading following Q1 earnings.
    Virtu Financial, Inc. (NASDAQ: VIRT) fell 5.3 percent to $31.1604 in pre-market trading after announcing a 15 million share common stock secondary offering.
    Papa John's International, Inc. (NASDAQ: PZZA) shares fell 4.7 percent to $56 in pre-market trading after reporting downbeat Q1 earnings

  • [By Joseph Griffin]

    Virtu Financial (NASDAQ: VIRT) and Nomura (NYSE:NMR) are both finance companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, earnings, risk, valuation, institutional ownership, dividends and analyst recommendations.

  • [By Jon C. Ogg]

    Virtu Financial Inc. (NASDAQ: VIRT) was started as Buy andassigned a $37 price target (versus a $29.10 close) at Jefferies. It has a consensus analyst target of almost $36 and a 52-week trading range of $13.10 to $37.85.

Q1 2018 EPS Estimates for vTv Therapeutics Decreased by Seaport Global Securities (VTVT)

vTv Therapeutics (NASDAQ:VTVT) – Equities researchers at Seaport Global Securities dropped their Q1 2018 earnings estimates for shares of vTv Therapeutics in a note issued to investors on Tuesday, April 10th. Seaport Global Securities analyst C. Davis now anticipates that the biotechnology company will post earnings per share of ($0.45) for the quarter, down from their previous estimate of ($0.30). Seaport Global Securities has a “Neutral” rating on the stock. Seaport Global Securities also issued estimates for vTv Therapeutics’ Q2 2018 earnings at ($0.26) EPS, Q3 2018 earnings at ($0.18) EPS, Q4 2018 earnings at ($0.16) EPS, FY2018 earnings at ($1.05) EPS, FY2019 earnings at ($0.48) EPS, FY2020 earnings at ($0.40) EPS and FY2022 earnings at ($0.32) EPS.

How to Become a New Pot Stock Millionaire

vTv Therapeutics (NASDAQ:VTVT) last released its earnings results on Tuesday, February 27th. The biotechnology company reported ($0.44) EPS for the quarter, missing analysts’ consensus estimates of ($0.41) by ($0.03). The firm had revenue of $0.23 million for the quarter, compared to analyst estimates of $0.10 million.

A number of other research firms have also recently commented on VTVT. Northland Securities began coverage on shares of vTv Therapeutics in a research note on Thursday, February 8th. They set an “outperform” rating and a $28.00 target price for the company. Roth Capital began coverage on shares of vTv Therapeutics in a research note on Thursday, March 8th. They set a “buy” rating and a $17.00 target price for the company. Zacks Investment Research cut shares of vTv Therapeutics from a “hold” rating to a “sell” rating in a research note on Saturday, March 3rd. Canaccord Genuity set a $15.00 target price on shares of vTv Therapeutics and gave the stock a “buy” rating in a research note on Thursday, December 21st. Finally, Stifel Nicolaus cut shares of vTv Therapeutics from a “buy” rating to a “hold” rating in a research note on Tuesday. One investment analyst has rated the stock with a sell rating, six have given a hold rating and two have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average target price of $13.69.

VTVT stock opened at $0.71 on Thursday. The stock has a market cap of $106.97, a PE ratio of -0.43 and a beta of 1.74. The company has a debt-to-equity ratio of -0.10, a current ratio of 0.76 and a quick ratio of 0.76. vTv Therapeutics has a 52 week low of $0.65 and a 52 week high of $8.40.

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. State Street Corp grew its stake in vTv Therapeutics by 2.1% during the 2nd quarter. State Street Corp now owns 98,016 shares of the biotechnology company’s stock valued at $486,000 after acquiring an additional 1,976 shares in the last quarter. Creative Planning purchased a new stake in vTv Therapeutics during the 4th quarter valued at about $114,000. Millennium Management LLC purchased a new stake in vTv Therapeutics during the 4th quarter valued at about $377,000. JPMorgan Chase & Co. purchased a new stake in vTv Therapeutics during the 3rd quarter valued at about $481,000. Finally, Royce & Associates LP purchased a new stake in vTv Therapeutics during the 4th quarter valued at about $1,352,000. 11.20% of the stock is owned by institutional investors.

COPYRIGHT VIOLATION NOTICE: “Q1 2018 EPS Estimates for vTv Therapeutics Decreased by Seaport Global Securities (VTVT)” was first reported by Ticker Report and is the sole property of of Ticker Report. If you are viewing this report on another site, it was illegally copied and reposted in violation of United States and international copyright and trademark law. The legal version of this report can be read at www.tickerreport.com/banking-finance/3350631/q1-2018-eps-estimates-for-vtv-therapeutics-decreased-by-seaport-global-securities-vtvt.html.

vTv Therapeutics Company Profile

vTv Therapeutics Inc, a clinical-stage biopharmaceutical company, discovers, develops, and sells orally administered small molecule drug candidates worldwide. The company's drug candidates comprise azeliragon (TTP488), an orally administered, small molecule antagonist targeting the receptor for advanced glycation endproducts, which is in Phase III clinical trials for the treatment of Alzheimer's disease.